GCG expression did not significantly influence survival outcomes in bladder cancer, esophageal squamous cell carcinoma, renal papillary cell carcinoma, lung adenocarcinoma, and pancreatic cancer. This evidence concerns the gene GCG and familial pancreatic carcinoma.